Discovering a Common Goal,
Discovering a Cure


Research News
Drug News
Conference News
< Home

Annexon Biosciences Closes $34M Series A Funding for Neurodegenerative and Autoimmune Disease Therapy
December 18, 2014
Redwood City, California-based Annexon Biosciences has closed a $34M Series A financing round to develop their lead candidate, ANX005, for treating autoimmune and neurodegenerative...

Brainscope’s Handheld TBI Assessment Device Receives FDA Clearance
December 18, 2014
A new handheld device developed by the medical neurotechnology company Brainscope has obtained clearance from the U.S. Food and Drug Administration (FDA) as an adjunctive technolo...

Otsuka Pharmaceutical to Acquire Avanir Pharmaceuticals
December 18, 2014
In late 2010, Avanir Pharmaceuticals obtained approval of the U.S. Food and Drug Administration (FDA) to market Nuedexta, the first drug for treating pseudobulbar effect, the uncon...

MIT Professor and Former Onyx CEO Co-found Neurodegenerative Disease-focused Company
December 15, 2014
Tony Coles, the former CEO of Onyx Pharmaceuticals, and Professor Susan Lindquist of MIT’s Whitehead Institute in Cambridge, Massachusetts have joined forces to found a new biote...

Isis Pharmaceuticals Initiates Phase III Study in Spinal Muscular Atrophy
December 2, 2014
Isis Pharmaceuticals, the California-based pharmaceutical company that specializes in antisense based drug development, has announced the initiation of a Phase III trial of ISIS-SM...

The ALS Forum was developed by Prize4Life, Inc.
© 2014 Prize4Life, Inc.
Identified content provided through
a partnership with the Alzforum